首页> 外文OA文献 >DIPG-36. ANTI-GD2 CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF HISTONE 3 K27M MUTANT DIFFUSE MIDLINE GLIOMA

【2h】

DIPG-36. ANTI-GD2 CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF HISTONE 3 K27M MUTANT DIFFUSE MIDLINE GLIOMA

机译：DIPG-36。抗GD2嵌合抗原受体T细胞作为组蛋白3k27m突变体弥漫性中线胶质瘤的异种移植模型中的有效免疫疗法方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Christopher Mount; Robbie Majzner; Shree Sundaresh; Evan Arnold; Meena Kadapakkam; Samuel Haile; Louai Labanieh; Pamelyn Woo; Skyler Rietberg; Hannes Vogel; Michelle Monje; Crystal Mackall;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression [J] . Lopez Giselle Y., Bush Nancy Ann Oberheim, Phillips Joanna J., Acta Neuropathologica . 2017,第6期

机译：弥漫中线胶质瘤与亚间链H3F3A K27M突变和马赛克H3.3 K27M突变蛋白表达
2. ANTI-GD2 CAR T CELLS ARE POTENT IN H3-K27M(+) DIFFUSE MIDLINE GLIOMAS [J] . Cancer discovery. . 2018,第6期

机译：抗GD2型汽车T细胞在H3-K27M（+）弥漫性中线胶质瘤中有效
3. Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M(+) diffuse midline gliomas [J] . Mount Christopher W., Majzner Robbie G., Sundaresh Shree, Nature medicine . 2018,第5期

机译：H3-K27M（+）弥漫性中线抗GD2汽车T细胞的有效抗肿瘤效果
4. Targeting the Disialoganglioside GD2 with Chimeric Antigen Receptor T Cells for Immunotherapy in Diffuse Midline Gliomas, and Exploration of Neuron-OPC Synaptic Connectivity in the Context of Adaptive Myelination [D] . Mount, Christopher W. 2020

机译：用嵌合抗原受体T细胞靶向Diaialoganglioside GD2，用于在弥漫性中线胶质瘤中的免疫疗法，以及在适应性髓鞘中的背景下探索神经元-Popaptic连通性
5. DIPG-36. ANTI-GD2 CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF HISTONE 3 K27M MUTANT DIFFUSE MIDLINE GLIOMA [O] . Christopher Mount, Robbie Majzner, Shree Sundaresh, 2018

机译：DIPG-36。组蛋白3 K27M突变扩散中线胶质瘤异种移植模型中抗-GD2嵌合抗原受体T细胞作为强效免疫治疗方案
6. PDTM-39. GD2-DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF DIFFUSE INTRINSIC PONTINE GLIOMA [O] . Christopher Mount, Robbie Majzner, Shree Sundaresh, 2017

机译：PDTM-39。 GD2针对嵌入式嵌入式脊髓瘤的异种移植模型中的高效免疫治疗方案的GD2 - 定向的嵌合抗原受体T细胞

DIPG-36. ANTI-GD2 CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF HISTONE 3 K27M MUTANT DIFFUSE MIDLINE GLIOMA

著录项

相似文献

相关主题

期刊订阅